{"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"description":"Research bone marrow aspirate is obtained to assess response (optional, but recommended), and to document complete remission, if applicable. Correlation to be determined upon completion of study treatment","groups":[{"description":"Pomalidomide: Comparison of different dosages and schedules of drug","id":"OG000","title":"Pomalidomide 2 mg/d on 28 Days/28 Day Cycle"},{"description":"Pomalidomide: Comparison of different dosages and schedules of drug","id":"OG001","title":"Pomalidomide 4 mg/d on 21 Days/28 Day Cycle"}],"populationDescription":"The actin polymerization assay that was to be used for this outcome was not reproducible and data were not analyzed.","reportingStatus":"POSTED","timeFrame":"Research bone marrow aspirate is obtained at baseline and after completion of 2 cycles of therapy (approximately 56 days)","title":"To Correlate Drug Induced Changes in F Actin Polymerization With Adverse Effects and Clinical Responses.","type":"SECONDARY"}